Free Trial

Organicell Regenerative Medicine (BPSR) SEC Filings & 10K Form

Organicell Regenerative Medicine logo
$1.97
0.00 (0.00%)
(As of 11/4/2024 ET)

Recent Organicell Regenerative Medicine SEC Filings

DateFilerForm TypeView
10/15/2024
7:30 AM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
5:01 AM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:52 PM
Skycrest Holdings, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
10:13 AM
Kompothecras Gary (Filed by)
Organicell Regenerative Medicine (Subject)
Form SC 13G
08/07/2024
3:49 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
6:00 PM
Grey Wendy (Reporting)
Greyt Ventures, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
4:20 PM
BOTHWELL IAN T (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
4:20 PM
Bretz Charles Luther (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
4:20 PM
GLAUSER STEVEN JERRY (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
4:21 PM
Shapiro George Craig (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
4:21 PM
Skycrest Holdings, LLC (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
4:22 PM
Stearn Leathem S (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:10 PM
Bretz Charles Luther (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:10 PM
GLAUSER STEVEN JERRY (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:11 PM
Stearn Leathem S (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:11 PM
Singh Gurvinder Pal (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:36 PM
Organicell Regenerative Medicine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/20/2023
5:30 AM
Organicell Regenerative Medicine (Filer)
Form DEF 14C
12/12/2023
3:15 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
4:00 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:29 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:BPSR) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners